Skip to main content
Zodiac Ventures Limited logo

Zodiac Ventures Limited — Investor Relations & Filings

Ticker · 503641 ISIN · INE945J01027 LEI · 984500038A14B3768552 BSE.NS Construction
Filings indexed 314 across all filing types
Latest filing 2025-05-30 Regulatory Filings
Country IN India
Listing BSE.NS 503641

About Zodiac Ventures Limited

https://zodiacventures.in/

Zodiac Ventures Limited focuses on the development, construction, and management of residential and commercial projects. The company specializes in urban redevelopment initiatives, transforming existing properties into modern residential complexes and commercial spaces. Its operations encompass the entire project lifecycle, from land acquisition and planning to design, execution, and marketing. The firm prioritizes the integration of contemporary architectural designs and functional amenities to cater to urban requirements. By utilizing advanced construction techniques and maintaining rigorous quality standards, the company aims to deliver high-quality infrastructure and living environments. Its portfolio includes a variety of projects ranging from luxury housing to functional office spaces, emphasizing structural durability and aesthetic appeal.

Recent filings

Filing Released Lang Actions
Outcome of the Board Meeting dated 30th May 2025.
Regulatory Filings
2025-05-30 English
Zodiac Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve the Audited Financial Results ....
Regulatory Filings Classification · 95% confidence The document is a notice of a Board Meeting scheduled to consider and approve the audited financial results for the quarter and fiscal year ending March 31, 2025. It is addressed to the stock exchange and references SEBI regulations. The document is short (1344 characters) and serves as an announcement of an upcoming meeting rather than containing any financial results or detailed reports itself. Therefore, it is not an Annual Report, Interim Report, or Earnings Release. It is also not a certification or voting result. The document fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement informing the market about the Board Meeting and the agenda to approve financial results.
2025-05-23 English
Intimation of receipt of in-principle approval letter from BSE Ltd. for proposed Rights Issue of the Company
Regulatory Filings
2025-04-11 English
Compliance Certificate under Regulation 74 (5) of the SEBI (DP) Regulations, 2018 for the quarter ended 31st March 2025.
Regulatory Filings Classification · 95% confidence The document is a certificate submitted under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 31st March 2025. It is a confirmation certificate related to dematerialisation of securities, signed by the company secretary and compliance officer, and confirmed by the registrar and transfer agent. The document is short (2987 characters) and primarily serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. It is a regulatory filing confirming compliance with SEBI regulations regarding securities dematerialisation. Therefore, it fits best under Regulatory Filings (RNS).
2025-04-11 English
Intimation of closure of trading window pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Regulatory Filings Classification · 95% confidence The document is a notice addressed to the Bombay Stock Exchange regarding the closure of the trading window for insiders pursuant to SEBI regulations. It mentions the trading window closure period related to the declaration of audited financial results for the quarter and year ended 31st March 2025. The document is short (1361 characters) and serves as an announcement about trading restrictions rather than containing any financial data or report. It does not contain financial statements, management discussion, or any detailed report content. Therefore, it is best classified as a Regulatory Filing (RNS), which covers compliance-related announcements and notices that do not fit other categories.
2025-03-29 English
Integrated Filing for the Unaudited Financial Results for the quarter ending on 31st December 2024.
Regulatory Filings
2025-02-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.